Cliftonlarsonallen Wealth Advisors LLC Invests $3.25 Million in Aflac Incorporated (NYSE:AFL)

Cliftonlarsonallen Wealth Advisors LLC acquired a new stake in Aflac Incorporated (NYSE:AFL - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 31,378 shares of the financial services provider's stock, valued at approximately $3,246,000.

Several other large investors also recently modified their holdings of the company. Darwin Wealth Management LLC acquired a new position in Aflac in the third quarter valued at approximately $34,000. Raelipskie Partnership bought a new stake in shares of Aflac in the 3rd quarter valued at $38,000. Covestor Ltd lifted its position in shares of Aflac by 41.8% during the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider's stock valued at $41,000 after acquiring an additional 107 shares during the period. Kennebec Savings Bank bought a new position in Aflac during the third quarter worth $45,000. Finally, Catalyst Capital Advisors LLC acquired a new stake in Aflac in the third quarter worth $51,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Aflac

In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the business's stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the transaction, the executive vice president now directly owns 222,618 shares in the company, valued at $23,018,701.20. The trade was a 10.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.90% of the company's stock.

Aflac Stock Up 1.1 %

Shares of AFL traded up $1.15 during trading hours on Wednesday, reaching $104.80. 2,004,767 shares of the stock traded hands, compared to its average volume of 1,684,561. Aflac Incorporated has a 52 week low of $75.07 and a 52 week high of $115.50. The company has a market cap of $58.22 billion, a price-to-earnings ratio of 15.78, a PEG ratio of 2.09 and a beta of 1.00. The stock has a fifty day simple moving average of $106.55 and a 200 day simple moving average of $105.12. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 0.32.

Aflac (NYSE:AFL - Get Free Report) last posted its earnings results on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, topping the consensus estimate of $1.69 by $0.47. The firm had revenue of $2.95 billion for the quarter, compared to analysts' expectations of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The company's quarterly revenue was down 40.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.84 EPS. On average, equities analysts forecast that Aflac Incorporated will post 7.27 EPS for the current year.

Aflac Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Wednesday, February 19th will be paid a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a yield of 2.21%. The ex-dividend date is Wednesday, February 19th. This is an increase from Aflac's previous quarterly dividend of $0.50. Aflac's dividend payout ratio is 34.94%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on AFL shares. Barclays upped their price objective on shares of Aflac from $96.00 to $98.00 and gave the company an "underweight" rating in a report on Monday, January 6th. Evercore ISI dropped their price target on Aflac from $104.00 to $102.00 and set an "underperform" rating on the stock in a research note on Wednesday, December 4th. Keefe, Bruyette & Woods cut their price target on Aflac from $108.00 to $107.00 and set a "market perform" rating on the stock in a report on Friday, January 10th. Truist Financial boosted their price objective on Aflac from $100.00 to $105.00 and gave the company a "hold" rating in a report on Friday, November 1st. Finally, JPMorgan Chase & Co. increased their target price on Aflac from $90.00 to $94.00 and gave the stock a "neutral" rating in a report on Tuesday, January 7th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $102.07.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.